TrialContemporary clinical trials2022

Ozanimod as a novel oral small molecule therapy for the treatment of Crohn's disease: The YELLOWSTONE clinical trial program.

Brian G Feagan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.